Phase 1 Hepatitis C Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Completed
Phase 1
A Phase 1, Open-Label, Four-Period, Two-Sequence, Two-Treatment, Single Dose, Randomized, Crossover Bioequivalence Study of a Test Tablet Formulation of Ravidasvir with the Reference Tablet Formulation of Ravidasvir in Healthy Adult Volunteers Under Fasting Conditions
Hepatitis C Virus (HCV)
Drug for Neglected Diseases initiative36 enrolled1 locationACTRN12620000037909
Terminated
Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Oral ACH-0143422 after Single and Multiple-ascending Doses in Health Volunteers and Subjects With Chronic Hepatitis C Virus Genotype 1 Infection.
This current study is being conducted in healthy volunteers to learn about the way this drug behaves in the body when it is given at different doses. The study will also be conducted in patients with Hepatitis C genotype 1.
Achillion Pharmaceuticals, Inc157 enrolled1 locationACTRN12614000304639
Completed
Phase 1
Assessment of the trial drugs ACH-0143102 and ACH-0142684, when taken by healthy men and women.
Phase 1 study (Healthy volunteers). Results to support research in Hepatitis C.
Achillion Pharmaceuticals, Inc36 enrolled1 locationACTRN12614000102673
Recruiting
Phase 1
A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002158 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects with Chronic Hepatitis C Genotype 1 Infection.
Chronic Hepatitis C infection
CPR Pharma Services78 enrolled4 locationsACTRN12612000176864
Not Yet Recruiting
Phase 1
Placebo-Controlled, Single and Multiple Ascending Dose Study of BMS-929075 in Healthy Subjects.
Hepatitis C
Bristol-Myers Squibb Company96 enrolled1 locationACTRN12611001038987
Completed
Phase 1
Community-based health organisations and chronic illness care
Access to community-based health organisations amongst patients with chronic illnessHaemochromatosisAsthma+4 more
Dr Fran Boyle, The University of Queensland650 enrolled1 locationACTRN12607000167460
Terminated
Phase 1
A phase Ib study of oglufanide disodium (IM862) in patients with chronic HCV infection
Chronic Hepatitis C
Implicit Bioscience Pty Ltd32 enrolled1 locationACTRN12606000505505